论文部分内容阅读
治疗无症状消化溃疡患者的唯一理由是减少再发的可能性或存在并发症的危险。接受H~2受体拮抗剂作维持治疗的患者无疑能减少十二指肠溃疡的症状发作,因而无症状的溃疡发生率也可能降低。对消化性溃疡患者的生命威胁通常是并存其他严重疾病(肝硬化、肾功衰等)或60岁以上的患
The only reason to treat asymptomatic patients with peptic ulcer disease is to reduce the risk of recurrence or the risk of complications. Patients who receive H 2 receptor antagonists for maintenance therapy will undoubtedly reduce the onset of symptoms of duodenal ulcers and thus may reduce the incidence of asymptomatic ulcers. Life-threatening patients with peptic ulcer disease are usually the coexistence of other serious diseases (cirrhosis, renal failure, etc.) or patients over the age of 60